A carregar...
Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study
BACKGROUND: Adjuvant tamoxifen therapy approximately halves the risk of estrogen receptor positive breast cancer recurrence, but many women do not respond to therapy. Observational studies nested in clinical trial populations suggest that overexpression or nuclear localization of p21-activated kinas...
Na minha lista:
| Publicado no: | Acta Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943575/ https://ncbi.nlm.nih.gov/pubmed/27056567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2016.1150606 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|